Interestingly, in breast cancer, where elevated IGFBP-6 correlates with improved survival, TCGA analysis found that IGFBP-6 expression also positively correlated with CD4+ and CD8+ T-cell and macrophage infiltration into the tumor microenvironment (TME) [35]. The gene discussed is IGFBP6; the disease is neoplasm.